BRPI0511454A - imunoensaio para plasmodium falciparum e instrumentos de ensaio usados - Google Patents

imunoensaio para plasmodium falciparum e instrumentos de ensaio usados

Info

Publication number
BRPI0511454A
BRPI0511454A BRPI0511454-3A BRPI0511454A BRPI0511454A BR PI0511454 A BRPI0511454 A BR PI0511454A BR PI0511454 A BRPI0511454 A BR PI0511454A BR PI0511454 A BRPI0511454 A BR PI0511454A
Authority
BR
Brazil
Prior art keywords
antibody
plasmodium falciparum
immunoassay
antigen
solid phase
Prior art date
Application number
BRPI0511454-3A
Other languages
English (en)
Inventor
Mi Jin Sohn
Seung Bum Yoo
Yeon Chul Kim
Jae Hoon Oh
Eunkyung Kim
Seung Ho Choo
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of BRPI0511454A publication Critical patent/BRPI0511454A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445—Plasmodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

IMUNOENSAIO PARA PLASMODIUM FALCIPARUM E INSTRUMENTOS DE ENSAIO USADOS São divulgados um imunoensaio do Plasmodium falciparum para determinar a presença/ausência via marcador específico e/ou seu anticorpo em conjugados ligados a um antígeno específico e/ou anticorpo presente em uma amostra, compreendendo a imobilização do antígeno e anticorpo específicos do Plasmodium falciparum em uma fase sólida, adicionando uma amostra obtida de um sujeito de interesse à fase sólida de forma a induzir reação antígeno-anticorpo específica, adicionando um conjugado do antígeno e um marcador e um conjugado do anticorpo e um marcador, preparados separadamente, a fim de induzir a ligação de pelo menos um dos conjugados; e um instrumento de ensaio compreendendo a fase sólida e os conjugados mencionados acima. A presente invenção pode causar a detecção de antígenos e/ou anticorpos em pacientes com manifestação de sintomas da malária assim como portadores da malária e também pode ser eficientemente empregada em amostras nos estágios iniciais da infecção da malária que é difícil de detectar via técnicas convencionais. Além disso, devido a capacidade de utilizar soro e plasma sanguíneo ao invés do sangue total, a presente invenção é bem adequada para exames em larga escala como triagem sangüínea.
BRPI0511454-3A 2004-06-30 2005-06-28 imunoensaio para plasmodium falciparum e instrumentos de ensaio usados BRPI0511454A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020040049985A KR101035111B1 (ko) 2004-06-30 2004-06-30 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단
PCT/KR2005/002010 WO2006004332A1 (en) 2004-06-30 2005-06-28 Immunoassay for plasmodium falciparum and assay device used therefor

Publications (1)

Publication Number Publication Date
BRPI0511454A true BRPI0511454A (pt) 2007-12-26

Family

ID=35783098

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511454-3A BRPI0511454A (pt) 2004-06-30 2005-06-28 imunoensaio para plasmodium falciparum e instrumentos de ensaio usados

Country Status (7)

Country Link
US (1) US20090197347A1 (pt)
KR (1) KR101035111B1 (pt)
CN (1) CN101014858A (pt)
AU (1) AU2005260377A1 (pt)
BR (1) BRPI0511454A (pt)
WO (1) WO2006004332A1 (pt)
ZA (1) ZA200608959B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9575061B2 (en) 2009-10-20 2017-02-21 Vanderbilt University Liquid drop diagnostic assays
CN102759621B (zh) * 2011-04-26 2016-02-24 复旦大学 基于微流控芯片的高通量快速检测疟疾血清的方法
CN106290879A (zh) * 2015-05-13 2017-01-04 上海凯创生物技术有限公司 恶性疟原虫胶体金法检测试剂盒
CN106290839A (zh) * 2015-05-13 2017-01-04 上海凯创生物技术有限公司 恶性疟原虫乳胶法检测试剂盒
CN108761065A (zh) * 2018-05-21 2018-11-06 苏州佑君环境科技有限公司 一种稀释碱性磷酸酶标识抗原用溶液及其制备方法
EP3971574A4 (en) * 2019-07-15 2022-06-08 Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences FUNCTIONALIZED BIOLOGICAL MULTILAYERY MEMBRANE IMMUNE SUPPORT, MANUFACTURING PROCESS AND APPLICATION
CN110343161B (zh) * 2019-07-30 2021-08-20 暨南大学 一种检测恶性疟原虫hrp2和间日疟原虫ldh的结合蛋白组合及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (de) * 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
US5130416A (en) * 1986-08-13 1992-07-14 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
FR2672290B1 (fr) * 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
IT1217582B (it) * 1988-05-13 1990-03-30 Eniricerche Spa Metodo immunoenzimatico in fase omogenea per la determinazione di anticorpi antisporozoita di plasmodium falciparum nel sangue umano
IT1226712B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Metodo immunoenzimatico elisa monopiastra con inibizione competitiva per la rivelazione di anticorpi antisporozoitari di plasmodium falciparum.
AU670108B2 (en) * 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
US6022748A (en) * 1997-08-29 2000-02-08 Sandia Corporation - New Mexico Regents Of The University Of California Sol-gel matrices for direct colorimetric detection of analytes
FR2735478B1 (fr) * 1995-06-13 1997-08-22 Pasteur Institut Molecules polypeptidiques de stade pre-erythrocytaire du paludisme
AUPN803796A0 (en) * 1996-02-13 1996-03-07 Council Of The Queensland Institute Of Medical Research, The Diagnostic assay for plasmodium falciparum
WO1998035057A1 (en) * 1997-02-06 1998-08-13 The National University Of Singapore Diagnosis of plasmodium infection by analysis of extrachromosomal genetic material
US7025961B1 (en) * 1999-03-04 2006-04-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-plasmodium composition and methods of use
US20020102620A1 (en) * 1999-05-07 2002-08-01 S. Melissa Maret Antibodies and peptides for detection of plasmodium vivax
AR027370A1 (es) * 2000-02-17 2003-03-26 Lg Chemical Ltd Inmunoensayo y reactivo de diagnostico para malaria, y correspondientes metodos de preparacion, vectores de expresion y transformantes
WO2002058727A2 (en) * 2001-01-26 2002-08-01 Walter Reed Army Institute Of Research Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
EP1423405A4 (en) * 2001-03-26 2005-01-05 Us Army AMA-1 PROTEIN OF PLASMODIUM FALCIPARUM AND ITS APPLICATIONS
EP1423091A4 (en) * 2001-08-10 2005-07-20 Univ California SENSITIVE AND RAPID DETECTION OF PATHOGENIC ORGANISMS AND TOXINS USING FLUORESCENT POLYMER LIPIDS
EP1497307B1 (en) * 2002-04-01 2016-08-03 Walter Reed Army Institute of Research Recombinant p.falciparum merozoite protein-1 42 vaccine
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
JP4824312B2 (ja) * 2002-11-26 2011-11-30 ユニバーシティ オブ ユタ リサーチ ファンデーション 微小孔物質、被分析物の局在化及び定量の方法、並びに被分析物の局在化及び定量用物品
AU2003296945A1 (en) * 2002-12-12 2004-07-09 Chiron Corporation Device and method for in-line blood testing using biochips
US20040248181A1 (en) * 2003-06-03 2004-12-09 Stenken Julie A. Method and kit for enhancing extraction and quantification of target molecules using microdialysis
US20060019406A1 (en) * 2004-07-23 2006-01-26 Ning Wei Lateral flow device for the detection of large pathogens
US20060127886A1 (en) * 2004-12-15 2006-06-15 Kaylor Rosann M Sample-efficient lateral flow immunoassay

Also Published As

Publication number Publication date
ZA200608959B (en) 2008-05-28
US20090197347A1 (en) 2009-08-06
CN101014858A (zh) 2007-08-08
AU2005260377A1 (en) 2006-01-12
WO2006004332A1 (en) 2006-01-12
KR101035111B1 (ko) 2011-05-19
KR20060000985A (ko) 2006-01-06

Similar Documents

Publication Publication Date Title
Diao et al. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection
BRPI0511454A (pt) imunoensaio para plasmodium falciparum e instrumentos de ensaio usados
ATE412179T1 (de) Nachweis von arzneistoffen der methamphetamingruppe
BRPI0411059A (pt) tiras de teste diagnóstico para detecção de um analito de interesse em uma amostra lìquida, para detecção de anticorpo de anti-hiv em uma amostra, e de teste de gravidez de imuno-diagnóstico, e, método de detecção de um anticorpo de interesse em uma amostra lìquida
BR112018016337A2 (pt) anticorpos monoclonais da proteína ns1 de vírus antidengue
NO20076656L (no) Forbedrede immunoassay metoder
Ezzat et al. Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy
JP4197180B2 (ja) 検体中の内分泌物質測定方法
WO2018152124A1 (en) Rapid immunochromatographic lateral flow assay for early zika disease detection
BR112012029769A2 (pt) processo para a detecção eletroquímica de reações de ligação
Song et al. Chip-based cartilage oligomeric matrix protein detection in serum and synovial fluid for osteoarthritis diagnosis
Downs et al. Correlation of serum and dried blood spot results for quantitation of Schistosoma circulating anodic antigen: a proof of principle
Hu et al. Detection of hepatitis B virus PreS1 antigen using a time-resolved fluoroimmunoassay
Loufouma-Mbouaka et al. Evaluation of rapid diagnostic tests and Enzyme Linked Immunoassay in the detection of malaria in ancient human remains
BR0200986A (pt) Ensaio de combinação anticorpo - antìgeno da hepatite c para a detecção precoce da infecção
Gholizadeh et al. Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls
Alcantara et al. Heparin in plasma samples causes nonspecific binding to histones on Western blots
Shah et al. Comparison of the analytic sensitivities of a recombinant immunoblot assay and the radioimmune precipitation assay for the detection of antibodies to Trypanosoma cruzi in patients with Chagas disease
BRPI1004526A2 (pt) dispositivo semi-quantitativo de immunochromatographico e método para a determinação de hiv/aids via medida de solúvel cd40 ligand/cd154, um cd4+ equivalente de célula de t e a detecção simultánea de infecção de hiv via detecção de anticorpo de hiv
Rungrojcharoenkit et al. Standardization of in-house anti-IgG and IgA ELISAs for the detection of COVID-19
Sarkari et al. A comparative study of antigen and antibody detection in visceral leishmaniasis using serum and urine-based ELISA
EP2444812A3 (en) Improved immunoassay methods
Bai Laboratory diagnosis of rickettsial infections
CN110741099B (zh) 评估个体的登革热病毒感染严重程度的方法、检测装置及检测试剂盒
TWI624668B (zh) 評估個體之登革熱病毒感染嚴重程度的方法

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.